Docosahexaenoic Acid Attenuated Experimental Chronic Colitis in Interleukin 10-Deficient Mice by Enhancing Autophagy Through Inhibition of the mTOR Pathway

Journal of Parenteral and Enteral Nutrition

Volumn 41, Issue 5, 2017, Pages 824-829

  Zhao, Jie ^a   Dong, Jian Ning ^a   Wang, Hong Gang ^a   Zhao, Mingli ^a   Sun, Jing ^a   Zhu, Wei Ming ^a   Zuo, Lu Gen ^a   Gong, Jian Feng ^a   Li, Yi ^a   Gu, Li Li ^a   Li, Ning ^a   Li, Jie Shou ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

Author keywords

autophagy; Crohn's disease; docosahexaenoic acid; interleukin 10 deficient mice; mTOR pathway

Indexed keywords

DOCOSAHEXAENOIC ACID; GAMMA INTERFERON; INTERLEUKIN 10; MAMMALIAN TARGET OF RAPAMYCIN; PLACEBO; TUMOR NECROSIS FACTOR; MTOR PROTEIN, MOUSE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; TARGET OF RAPAMYCIN KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASCENDING COLON; AUTOPHAGY; COLON; CONTROLLED STUDY; DISEASE SEVERITY; EXPERIMENTAL CHRONIC COLITIS; EXPERIMENTAL COLITIS; INFLAMMATORY CELL; MOUSE; MUCOSA; NONHUMAN; PRIORITY JOURNAL; WILD TYPE; ANIMAL; ANTAGONISTS AND INHIBITORS; BLOOD; C57BL MOUSE; CHRONIC DISEASE; COLITIS; DEFICIENCY; DISEASE MODEL; DRUG EFFECTS; GENETICS; KNOCKOUT MOUSE; METABOLISM; SIGNAL TRANSDUCTION;

ANIMALS; AUTOPHAGY; CHRONIC DISEASE; COLITIS; COLON; DISEASE MODELS, ANIMAL; DOCOSAHEXAENOIC ACIDS; INTERFERON-GAMMA; INTERLEUKIN-10; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 85026435258     PISSN: 01486071     EISSN: 19412444     Source Type: Journal    
DOI: 10.1177/0148607115609308     Document Type: Article

References (47)

1. Marcuzzi A, Bianco AM, Girardelli M, et al. Genetic and functional profiling of Crohn's disease: autophagy mechanism and susceptibility to infectious diseases. Biomed Res Int. 2013; 2013:297501.
2. Goettel JA, Scott AH, Olivares-Villagomez D, et al. KSR1 protects from interleukin-10 deficiency-induced colitis in mice by suppressing T-lymphocyte interferon-gamma production. Gastroenterology. 2011; 140: 265-274.
3. Zhou XJ, Zhang H,. Autophagy in immunity: implications in etiology of autoimmune/autoinflammatory diseases. Autophagy. 2012; 8: 1286-1299.
4. Plantinga TS, Joosten LA, van der Meer JW, Netea MG,. Modulation of inflammation by autophagy: consequences for Crohn's disease. Curr Opin Pharmacol. 2012; 12: 497-502.
5. Yuk JM, Yoshimori T, Jo EK,. Autophagy and bacterial infectious diseases. Exp Mol Med. 2012; 44: 99-108.
6. Hampe J, Franke A, Rosenstiel P, et al. A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nat Genet. 2007; 39: 207-211.
7. McCarroll SA, Huett A, Kuballa P, et al. Deletion polymorphism upstream of IRGM associated with altered IRGM expression and Crohn's disease. Nat Genet. 2008; 40: 1107-1112.
8. Cooney R, Baker J, Brain O, et al. NOD2 stimulation induces autophagy in dendritic cells influencing bacterial handling and antigen presentation. Nat Med. 2010; 16: 90-97.
9. Nys K, Agostinis P, Vermeire S,. Autophagy: a new target or an old strategy for the treatment of Crohn's disease? Nat Rev Gastroenterol Hepatol. 2013; 10: 395-401.
10. Marion-Letellier R, Raman M, Savoye G, Dechelotte P, Ghosh S,. Nutrient modulation of autophagy: implications for inflammatory bowel diseases. Inflamm Bowel Dis. 2013; 19: 205-212.
11. Stewart M, Day AS, Otley A,. Physician attitudes and practices of enteral nutrition as primary treatment of paediatric Crohn disease in North America. J Pediatr Gastroenterol Nutr. 2011; 52: 38-42.
12. Borrelli O, Cordischi L, Cirulli M, et al. Polymeric diet alone versus corticosteroids in the treatment of active pediatric Crohn's disease: a randomized controlled open-label trial. Clin Gastroenterol Hepatol. 2006; 4: 744-753.
13. Froslie KF, Jahnsen J, Moum BA, Vatn MH,. Mucosal healing in inflammatory bowel disease: results from a Norwegian population-based cohort. Gastroenterology. 2007; 133: 412-422.
14. Hashimoto T, Perlot T, Rehman A, et al. ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation. Nature. 2012; 487: 477-481.
15. Marion-Letellier R, Savoye G, Beck PL, Panaccione R, Ghosh S,. Polyunsaturated fatty acids in inflammatory bowel diseases: a reappraisal of effects and therapeutic approaches. Inflamm Bowel Dis. 2013; 19: 650-661.
16. Calder PC,. Omega-3 polyunsaturated fatty acids and inflammatory processes: nutrition or pharmacology? Br J Clin Pharmacol. 2013; 75: 645-662.
17. El-Sharkawy H, Aboelsaad N, Eliwa M, et al. Adjunctive treatment of chronic periodontitis with daily dietary supplementation with omega-3 fatty acids and low-dose aspirin. J Periodontol. 2010; 81: 1635-1643.
18. Weylandt KH, Chiu CY, Gomolka B, Waechter SF, Wiedenmann B,. Omega-3 fatty acids and their lipid mediators: towards an understanding of resolvin and protectin formation. Prostaglandins Other Lipid Mediat. 2012; 97: 73-82.
19. Shin S, Jing K, Jeong S, et al. The omega-3 polyunsaturated fatty acid DHA induces simultaneous apoptosis and autophagy via mitochondrial ROS-mediated Akt-mTOR signaling in prostate cancer cells expressing mutant p53. Biomed Res Int. 2013; 2013: 568671.
20. Shi CS, Shenderov K, Huang NN, et al. Activation of autophagy by inflammatory signals limits IL-1beta production by targeting ubiquitinated inflammasomes for destruction. Nat Immunol. 2012; 13: 255-263.
21. Van Noolen L, Back M, Arnaud C, et al. Docosahexaenoic acid supplementation modifies fatty acid incorporation in tissues and prevents hypoxia induced-atherosclerosis progression in apolipoprotein-E deficient mice [published online August 4, 2014]. Prostaglandins Leukot Essent Fatty Acids.
22. Huang S, Dai Y, Zhang Z, Hao W, Chen H,. Docosahexaenoic acid intake ameliorates ketamine-induced impairment of spatial cognition and learning ability in ICR mice. Neurosci Lett. 2014; 580: 125-129.
23. Singh UP, Singh S, Taub DD, Lillard JJ,. Inhibition of IFN-gamma-inducible protein-10 abrogates colitis in IL-10-/- mice. J Immunol. 2003; 171: 1401-1406.
24. Li Y, Yu C, Zhu WM, et al. Triptolide ameliorates IL-10-deficient mice colitis by mechanisms involving suppression of IL-6/STAT3 signaling pathway and down-regulation of IL-17. Mol Immunol. 2010; 47: 2467-2474.
25. Coulombe F, Behr MA,. Crohn's disease as an immune deficiency? Lancet. 2009; 374: 769-770.
26. Kiss MH, Magalhaes CS,. Autoinflammatory diseases: mimics of autoimmunity or part of its spectrum? Case presentation. J Clin Immunol. 2008; 28 (suppl 1): S84-S89.
27. Cabre E, Manosa M, Gassull MA,. Omega-3 fatty acids and inflammatory bowel diseases: a systematic review. Br J Nutr. 2012; 107 (suppl 2): S240-S252.
28. Calder PC,. The 2008 ESPEN Sir David Cuthbertson Lecture: fatty acids and inflammation-from the membrane to the nucleus and from the laboratory bench to the clinic. Clin Nutr. 2010; 29: 5-12.
29. Endres S, Ghorbani R, Kelley VE, et al. The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N Engl J Med. 1989; 320: 265-271.
30. Yamada H, Yoshida M, Nakano Y, et al. In vivo and in vitro inhibition of monocyte adhesion to endothelial cells and endothelial adhesion molecules by eicosapentaenoic acid. Arterioscler Thromb Vasc Biol. 2008; 28: 2173-2179.
31. Kroetz DL, Zeldin DC,. Cytochrome P450 pathways of arachidonic acid metabolism. Curr Opin Lipidol. 2002; 13: 273-283.
32. Deretic V,. Autophagy in immunity and cell-autonomous defense against intracellular microbes. Immunol Rev. 2011; 240: 92-104.
33. Zhou XJ, Zhang H,. Autophagy in immunity: implications in etiology of autoimmune/autoinflammatory diseases. Autophagy. 2012; 8: 1286-1299.
34. Ng SC, Tsoi KK, Kamm MA, et al. Genetics of inflammatory bowel disease in Asia: systematic review and meta-analysis. Inflammatory Bowel Diseases. 2012; 18: 1164-1176.
35. Cadwell K, Patel KK, Maloney NS, et al. Virus-plus-susceptibility gene interaction determines Crohn's disease gene Atg16L1 phenotypes in intestine. Cell. 2010; 141: 1135-1145.
36. Williams-Bey Y, Boularan C, Vural A, et al. Omega-3 free fatty acids suppress macrophage inflammasome activation by inhibiting NF-kappaB activation and enhancing autophagy. PLoS One. 2014; 9: e97957.
37. Marion-Letellier R, Savoye G, Beck PL, Panaccione R, Ghosh S,. Polyunsaturated fatty acids in inflammatory bowel diseases: a reappraisal of effects and therapeutic approaches. Inflamm Bowel Dis. 2013; 19: 650-661.
38. Hsu HC, Chen CY, Chiang CH, Chen MF,. Eicosapentaenoic acid attenuated oxidative stress-induced cardiomyoblast apoptosis by activating adaptive autophagy. Eur J Nutr. 2014; 53: 541-547.
39. Fukui M, Kang KS, Okada K, Zhu BT,. EPA, an omega-3 fatty acid, induces apoptosis in human pancreatic cancer cells: role of ROS accumulation, caspase-8 activation, and autophagy induction. J Cell Biochem. 2013; 114: 192-203.
40. Eom JM, Seo MJ, Baek JY, et al. Alpha-eleostearic acid induces autophagy-dependent cell death through targeting AKT/mTOR and ERK1/2 signal together with the generation of reactive oxygen species. Biochem Biophys Res Commun. 2010; 391: 903-908.
41. Plantinga TS, Joosten LA, van der Meer JW, Netea MG,. Modulation of inflammation by autophagy: consequences for Crohn's disease. Curr Opin Pharmacol. 2012; 12: 497-502.
42. Chen R, Zou Y, Mao D, et al. The general amino acid control pathway regulates mTOR and autophagy during serum/glutamine starvation. J Cell Biol. 2014; 206: 173-182.
43. Jing K, Song KS, Shin S, et al. Docosahexaenoic acid induces autophagy through p53/AMPK/mTOR signaling and promotes apoptosis in human cancer cells harboring wild-type p53. Autophagy. 2011; 7: 1348-1358.
44. Andrade-Vieira R, Han JH, Marignani PA,. Omega-3 polyunsaturated fatty acid promotes the inhibition of glycolytic enzymes and mTOR signaling by regulating the tumor suppressor LKB1. Cancer Biol Ther. 2013; 14: 1050-1058.
45. Pang Y, Si M, Sun B, et al. DHA2, a synthesized derivative of bisbibenzyl, exerts antitumor activity against ovarian cancer through inhibition of XIAP and Akt/mTOR pathway. Food Chem Toxicol. 2014; 69: 163-174.
46. Stappenbeck TS, Rioux JD, Mizoguchi A, et al. Crohn disease: a current perspective on genetics, autophagy and immunity. Autophagy. 2011; 7: 355-374.
47. Garcia-Maurino S, Alcaide A, Dominguez C,. Pharmacological control of autophagy: therapeutic perspectives in inflammatory bowel disease and colorectal cancer. Curr Pharm Des. 2012; 18: 3853-3873.